Almirall SA (LBTSF)
15.35
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
Almirall Net Income (Quarterly) : 28.20M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 28.20M |
| March 31, 2016 | 23.92M |
| December 31, 2015 | 64.03M |
| September 30, 2015 | 16.12M |
| June 30, 2015 | 17.58M |
| March 31, 2015 | 48.23M |
| December 31, 2014 | 506.53M |
| September 30, 2014 | 31.55M |
| June 30, 2014 | 11.66M |
| March 31, 2014 | 14.52M |
| December 31, 2013 | -75.55M |
| September 30, 2013 | 5.562M |
| June 30, 2013 | 9.660M |
| March 31, 2013 | 13.47M |
| December 31, 2012 | -19.59M |
| September 30, 2012 | 80.52M |
| June 30, 2012 | 11.16M |
| March 31, 2012 | 23.99M |
| December 31, 2011 | -6.242M |
| September 30, 2011 | 29.65M |
| June 30, 2011 | 53.46M |
| Date | Value |
|---|---|
| March 31, 2011 | 41.87M |
| December 31, 2010 | -3.251M |
| September 30, 2010 | 44.03M |
| June 30, 2010 | 45.71M |
| March 31, 2010 | 70.48M |
| December 31, 2009 | 15.94M |
| September 30, 2009 | 53.32M |
| June 30, 2009 | 53.81M |
| March 31, 2009 | 83.07M |
| December 31, 2008 | 4.609M |
| September 30, 2008 | 70.77M |
| June 30, 2008 | 62.86M |
| March 31, 2008 | 67.82M |
| December 31, 2007 | 7.640M |
| September 30, 2007 | 45.24M |
| June 30, 2007 | 57.62M |
| March 31, 2007 | 65.84M |
| December 31, 2006 | 131.55M |
| June 30, 2006 | 61.36M |
| March 31, 2006 | 54.38M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Laboratorios Farmaceúticos Rovi SA | 87.12M |
| Eli Lilly & Co. | 7.095B |
| AstraZeneca PLC | 3.076B |
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 362.43M |
| Total Expenses (Quarterly) | 334.23M |
| EPS Diluted (Quarterly) | 0.1298 |
| Enterprise Value | 3.304B |
| Gross Profit Margin (Quarterly) | 25.76% |
| Profit Margin (Quarterly) | 7.78% |
| Earnings Yield | 2.08% |
| Operating Earnings Yield | 3.39% |
| Normalized Earnings Yield | 2.03 |